These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells. Myerburg MM; King JD; Oyster NM; Fitch AC; Magill A; Baty CJ; Watkins SC; Kolls JK; Pilewski JM; Hallows KR Am J Respir Cell Mol Biol; 2010 Jun; 42(6):676-84. PubMed ID: 19617399 [TBL] [Abstract][Full Text] [Related]
16. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Garcia-Caballero A; Rasmussen JE; Gaillard E; Watson MJ; Olsen JC; Donaldson SH; Stutts MJ; Tarran R Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11412-7. PubMed ID: 19541605 [TBL] [Abstract][Full Text] [Related]
17. Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC). Qadri YJ; Cormet-Boyaka E; Rooj AK; Lee W; Parpura V; Fuller CM; Berdiev BK J Biol Chem; 2012 May; 287(20):16781-90. PubMed ID: 22442149 [TBL] [Abstract][Full Text] [Related]
18. Effect of neutrophil elastase and its inhibitor EPI-hNE4 on transepithelial sodium transport across normal and cystic fibrosis human nasal epithelial cells. Prulière-Escabasse V; Clerici C; Vuagniaux G; Coste A; Escudier E; Planès C Respir Res; 2010 Oct; 11(1):141. PubMed ID: 20932306 [TBL] [Abstract][Full Text] [Related]
19. ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art. Althaus M Curr Mol Pharmacol; 2013 Mar; 6(1):3-12. PubMed ID: 23547930 [TBL] [Abstract][Full Text] [Related]
20. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease. Moore PJ; Tarran R Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]